Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT03552354
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT03552354
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03552354. Allocation not applicable; no masking; primary purpose treatment. Start 2017-10-25 (actual); primary completion 2018-10-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
- Condition
- Stroke, Ischemic
- Intervention (Drug)
- Argatroban plus dual antiplatelet
- Lead sponsor
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct03552354- Content hash
fc68388200e37ec7967dd6f531afe7b4a65e7dcdfa83bf49392f1201bd9dd820